Foundations Investment Advisors, LLC Cardiol Therapeutics Inc. Transaction History
Foundations Investment Advisors, LLC
- $4.46 Billion
- Q3 2024
A detailed history of Foundations Investment Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Foundations Investment Advisors, LLC holds 161,950 shares of CRDL stock, worth $302,846. This represents 0.01% of its overall portfolio holdings.
Number of Shares
161,950
Previous 48,000
237.4%
Holding current value
$302,846
Previous $96,000
233.33%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRDL
# of Institutions
46Shares Held
5.61MCall Options Held
162KPut Options Held
7.4K-
Tejara Capital LTD London, X01.72MShares$3.22 Million1.26% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.47MShares$2.74 Million0.55% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9924KShares$1.73 Million0.36% of portfolio
-
Lion Street Advisors, LLC273KShares$511,0350.19% of portfolio
-
Cambridge Investment Research Advisors, Inc.116KShares$217,1640.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $116M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...